positron emission tomography/computed tomography

PROCEDURE17 trials

Sponsors

Warwick Medical School, Abramson Cancer Center at Penn Medicine, Roswell Park Cancer Institute, Virginia Commonwealth University, Stanford University

Conditions

Adenocarcinoma of the ProstateAdult MedulloblastomaAdult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)Bone CancerBreast CancerChildhood MedulloblastomaClear Cell Renal Cell CarcinomaHER2-positive Breast Cancer

Phase 1

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

TerminatedNCT01174199

Roswell Park Cancer InstituteAdenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Prostate Cancer +2

Start: 2012-02-29End: 2016-08-31Updated: 2022-10-03

Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC

TerminatedNCT01283178

Virginia Commonwealth UniversitySalivary Gland Squamous Cell Carcinoma, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx +13

Start: 2011-07-31End: 2016-09-30Updated: 2016-10-31

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

CompletedNCT02146222

University of Wisconsin, MadisonUnspecified Adult Solid Tumor, Protocol Specific

Start: 2014-09-30End: 2016-12-31Updated: 2019-11-18

[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

RecruitingNCT04989959

Orhan Kemal OzClear Cell Renal Cell Carcinoma, Renal Cell Carcinoma

Start: 2021-08-18End: 2027-08-18Target: 35Updated: 2025-12-04

Phase 2

Brivanib Metastatic Renal Cell Carcinoma

TerminatedNCT01253668

Abramson Cancer Center at Penn MedicineRenal Cell Carcinoma

Start: 2011-11-30End: 2013-09-30Updated: 2021-04-13

Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT

CompletedNCT01869725

Sue O'DorisioAdult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma +2

Start: 2013-04-01End: 2018-12-26Updated: 2021-09-22

89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

RecruitingNCT04006522

James BrugarolasRenal Cell Carcinoma

Start: 2019-10-02End: 2026-12-31Target: 55Updated: 2026-02-20

The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer

CompletedNCT04179968

Dana MathewsProstate Cancer, Prostate Cancer Metastatic

Start: 2020-01-27End: 2022-07-15Updated: 2023-03-20

68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer

WithdrawnNCT04483414

Dana MathewsProstate Cancer, Prostate Cancer Metastatic, Prostate Cancer Metastatic to Bone

Start: 2021-03-19End: 2023-04-05Updated: 2023-05-19

Biomarkers to Detect Endocrine Therapy Resistance

RecruitingNCT06067503

University of Wisconsin, MadisonBreast Cancer, Lobular Breast Carcinoma, Metastatic Cancer

Start: 2024-04-30End: 2026-08-31Target: 8Updated: 2025-04-22

Phase 3

PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer

Warwick Medical SchoolHead and Neck Cancer

Start: 2007-09-30Target: 560Updated: 2013-08-26

Unknown Phase

Positron Emission Tomography in Monitoring Treatment Response in Women With Newly Diagnosed Breast Cancer

WithdrawnNCT01018251

Abramson Cancer Center at Penn MedicineAdult Women With a New Diagnosis of Invasive Breast Cancer (Have Not Undergone Treatment)

Start: 2009-03-31End: 2011-06-30Updated: 2015-12-15

Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer

TerminatedNCT01541358

Stanford UniversityBone Cancer

Start: 2012-05-31End: 2012-09-30Updated: 2017-06-14

PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer

TerminatedNCT01712815

University of Southern CaliforniaHER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer +6

Start: 2013-11-22End: 2022-11-01Updated: 2023-08-14

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

CompletedNCT01892540

Case Comprehensive Cancer CenterBreast Cancer, Unspecified Adult Solid Tumor, Protocol Specific

Start: 2013-05-31End: 2015-06-30Updated: 2020-03-04

MRI Compared to PET/CT for Staging and Treatment Response in Lymphoma

Guangxi Medical UniversityLymphoma

Start: 2016-02-29Target: 66Updated: 2016-04-12

Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer

Dana MathewsProstate Cancer, Prostate Cancer Metastatic, Prostate Cancer Recurrent

Updated: 2023-09-11

Related Papers

Characterization of suspicious prostate lesions at multiparametric MRI with dynamic <sup>68</sup> Ga-Gozetotide PET/CT.

2025-10-13

ImmunoPET Imaging with 89Zr-Labeled Atezolizumab Enables <i>In Vivo</i> Evaluation of PD-L1 in Tumorgraft Models of Renal Cell Carcinoma

Clinical Cancer Research2022-09-0820 citations

Abstract 2478: Development of a novel HIF2a PET tracer: From proof of concept to a clinical trial

Cancer Research2022-06-152 citations

Abstract 1234: PD-L1 PET: A potential biomarker of checkpoint inhibitor sensitivity in renal cancer

Cancer Research2022-06-15

Diagnostic accuracy of pelvic magnetic resonance imaging for the assessment of bone marrow involvement in diffuse large B-cell lymphoma

PLoS ONE2021-05-277 citations

An exploratory study of 89Zr-DFO-Atezolizumab ImmunoPET/CT in patients with locally advanced or metastatic renal cell carcinoma.

Journal of Clinical Oncology2020-02-193 citations

Is PET-CT guided management for patients with locally advanced head and neck squamous cell cancer (HNSCC) cost-effective? Results from a UK non-inferiority phase III randomized trial.

Journal of Clinical Oncology2015-05-201 citations

Pharmacodynamic study using FLT PET/CT in advanced solid malignancies treated with a sequential combination of X-82 and docetaxel.

Journal of Clinical Oncology2015-05-20

Results of a feasibility study of I-124 girentuximab in metastatic clear cell renal cell carcinoma (m ccRCC).

Journal of Clinical Oncology2014-02-01